A Lifeline for Rare Diseases
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
Enhanced advanced premium tax credits have lowered costs and expanded access for tens of millions of Americans. This infographic breaks down how making these tax credits permanent will protect affordable individual coverage and care for families across the nation.
To address lack maternal mental health disparities, ACHP developed a research agenda that prioritizes and is informed by people with lived experience of toxic stress and racism.
To address challenges in AI advancement in health care, ACHP is promoting three key principles that are essential to appropriate and effective oversight.
ACHP released answers to frequently asked questions on broker compensation reform in the CY 2025 MA and Part D Policy and Technical Changes Final Rule from CMS.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.